← Browse by Condition
Medical Condition

unknown primary cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05576974 Phase 2
Recruiting

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Enrollment
120 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →